StatPearls, LLC

  • Asthma
  • Bronchodilator Agents
  • Cholinergic Antagonists
  • Pulmonary Disease, Chronic Obstructive

Bronchodilators

Bronchodilators are essential therapeutic agents indicated for patients with lower-than-optimal airflow through the lungs due to obstructive airway conditions. The primary classes include beta-2 agonists and anticholinergic agents, both of which act on the smooth muscle of the bronchioles to facilitate airway dilation. These medications are widely used in the management of asthma and chronic obstructive pulmonary disease, either to rapidly reverse acute symptoms or to improve baseline lung function in chronic disease. This activity provides a comprehensive review of bronchodilators essential agents in managing obstructive airway diseases covering their indications, mechanisms of action, and contraindications. This activity also addresses adverse event profiles, toxicity, monitoring requirements, and clinically significant drug interactions to support safe and effective clinical use. This activity also highlights the importance of interprofessional collaboration among healthcare providers to optimize therapeutic outcomes and ensure effective, patient-centered care. Additionally, this activity emphasizes a comprehensive understanding of bronchodilator pharmacology and the evidence-based application of therapy. By equipping healthcare professionals to tailor treatment according to clinical presentation and disease severity, the activity supports improved respiratory function, fewer exacerbations, and enhanced quality of life for patients with obstructive pulmonary diseases.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 2 creditsAMA PRA Category 1 Credit™Up to 2 creditsNursingUp to 2 creditsPharmacyUp to 2 credits

MOC types

ABS — Accredited CMEUp to 2 pointsABOS — Accredited CMEUp to 2 pointsABPATH — Lifelong LearningUp to 2 pointsABA — Lifelong LearningUp to 2 pointsABTS — Accredited CMEUp to 2 pointsABIM — Medical KnowledgeUp to 2 pointsABS — Self-AssessmentUp to 2 pointsABP — Lifelong Learning and Self-AssessmentUp to 2 pointsABTS — Self-AssessmentUp to 2 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Cross-Specialty

Relevant across 12 specialties.

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 2 credits
  • MOC · Up to 2 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left